Prophylactic oral ganciclovir after renal transplantation-dosing and pharmacokinetics View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1998-01

AUTHORS

Guido Filler, Dagmar Lampe, Moritz A. von Bredow, Marianne Lappenberg-Pelzer, Sonja Rocher, Jürgen Strehlau, Jochen H. H. Ehrich

ABSTRACT

Ganciclovir alone or in combination with hyperimmunoglobulin is replacing other treatment modalities for the prophylactic treatment of cytomegalovirus (CMV) infections. No dose recommendations are available for oral ganciclovir therapy in children with impaired renal function after renal transplantation of a kidney from a CMV IgG-positive donor. We undertook a pharmacokinetic study in 14 pediatric renal transplant recipients who were CMV IgG negative and had received a graft from a CMV IgG-positive donor. We estimated the daily dosage of oral ganciclovir in relation to the glomerular filtration rate (GFR). Oral ganciclovir was administered at a starting dose of 3 x 1 g for children with a weight above 50 kg, 3 x 750 mg for children between 50 and 37.5 kg, and 3 x 500 mg for children between 37.5 and 24 kg. The starting dose was reduced by 50% for GFR values < or = 50 ml/min per 1.73 m2 and by 75% for GFR values < or = 25 ml/min per 1.73 m2. The daily dose was divided into three daily doses unless GFR was < 40 ml/ min per 1.73 m2, when only two daily doses were given. Doses were adjusted according to the measured plasma trough concentrations (c) using the simple formula: c(ganciclovir)(measured)/c(ganciclovir)(desired) = dosage rate(used)/dosage rate(adjusted). Mean stable plasma trough concentration was 0.91 +/- 0.68 microg/ml. The dosage rate, adjusted to a trough concentration of 1.0 microg/ml, correlated with the GFR. The dose per day could be calculated according to a simple equation for a GFR < 100 ml/min per 1.73 m2: dosage per day (mg/kg per day) = GFR. No CMV disease developed in any of the patients during oral ganciclovir, but 1 patient developed an acute rejection episode and a positive pp65 antigen 5 weeks after discontinuation of ganciclovir. The drug was well tolerated and without side effects. More... »

PAGES

6-9

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s004670050391

DOI

http://dx.doi.org/10.1007/s004670050391

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1048067036

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9502557


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antiviral Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Area Under Curve", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biological Availability", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytomegalovirus Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ganciclovir", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections, Intravenous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Pediatric Nephrology, Charit\u00e9 Hospital, Humboldt University, Berlin, Germany, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Filler", 
        "givenName": "Guido", 
        "id": "sg:person.01071536417.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071536417.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Institute of Clinical Toxicology and Pharmacology, BBGes, Berlin, Germany, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lampe", 
        "givenName": "Dagmar", 
        "id": "sg:person.01327674261.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327674261.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Pediatric Nephrology, Charit\u00e9 Hospital, Humboldt University, Berlin, Germany, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "von Bredow", 
        "givenName": "Moritz A.", 
        "id": "sg:person.01030242017.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030242017.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Institute of Clinical Toxicology and Pharmacology, BBGes, Berlin, Germany, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lappenberg-Pelzer", 
        "givenName": "Marianne", 
        "id": "sg:person.01005150043.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005150043.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Institute of Clinical Toxicology and Pharmacology, BBGes, Berlin, Germany, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rocher", 
        "givenName": "Sonja", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Pediatric Nephrology, Charit\u00e9 Hospital, Humboldt University, Berlin, Germany, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Strehlau", 
        "givenName": "J\u00fcrgen", 
        "id": "sg:person.0726536625.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726536625.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Pediatric Nephrology, Charit\u00e9 Hospital, Humboldt University, Berlin, Germany, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ehrich", 
        "givenName": "Jochen H. H.", 
        "id": "sg:person.012521232474.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012521232474.34"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00861586", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009391840", 
          "https://doi.org/10.1007/bf00861586"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1164/ajrccm.150.1.8025741", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011029637"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hep.1840160202", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014545792"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00866315", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017583818", 
          "https://doi.org/10.1007/bf00866315"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(95)92110-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020852311"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(95)92110-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020852311"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(96)90449-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025511504"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00852868", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032557089", 
          "https://doi.org/10.1007/bf00852868"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jmv.1890400103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035171393"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.1989.03420240121038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036498475"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/clpt.1986.177", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048491269", 
          "https://doi.org/10.1038/clpt.1986.177"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/clinids/10.supplement_3.s507", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059470685"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/infdis/152.4.833", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059699619"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/infdis/155.3.565", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059700292"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007890-199605150-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060275860"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007890-199605150-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060275860"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007890-199605150-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060275860"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-123-3-199508010-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073699813"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ndt/8.9.858", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082724330"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1998-01", 
    "datePublishedReg": "1998-01-01", 
    "description": "Ganciclovir alone or in combination with hyperimmunoglobulin is replacing other treatment modalities for the prophylactic treatment of cytomegalovirus (CMV) infections. No dose recommendations are available for oral ganciclovir therapy in children with impaired renal function after renal transplantation of a kidney from a CMV IgG-positive donor. We undertook a pharmacokinetic study in 14 pediatric renal transplant recipients who were CMV IgG negative and had received a graft from a CMV IgG-positive donor. We estimated the daily dosage of oral ganciclovir in relation to the glomerular filtration rate (GFR). Oral ganciclovir was administered at a starting dose of 3 x 1 g for children with a weight above 50 kg, 3 x 750 mg for children between 50 and 37.5 kg, and 3 x 500 mg for children between 37.5 and 24 kg. The starting dose was reduced by 50% for GFR values < or = 50 ml/min per 1.73 m2 and by 75% for GFR values < or = 25 ml/min per 1.73 m2. The daily dose was divided into three daily doses unless GFR was < 40 ml/ min per 1.73 m2, when only two daily doses were given. Doses were adjusted according to the measured plasma trough concentrations (c) using the simple formula: c(ganciclovir)(measured)/c(ganciclovir)(desired) = dosage rate(used)/dosage rate(adjusted). Mean stable plasma trough concentration was 0.91 +/- 0.68 microg/ml. The dosage rate, adjusted to a trough concentration of 1.0 microg/ml, correlated with the GFR. The dose per day could be calculated according to a simple equation for a GFR < 100 ml/min per 1.73 m2: dosage per day (mg/kg per day) = GFR. No CMV disease developed in any of the patients during oral ganciclovir, but 1 patient developed an acute rejection episode and a positive pp65 antigen 5 weeks after discontinuation of ganciclovir. The drug was well tolerated and without side effects.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s004670050391", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1097267", 
        "issn": [
          "0931-041X", 
          "1432-198X"
        ], 
        "name": "Pediatric Nephrology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "name": "Prophylactic oral ganciclovir after renal transplantation-dosing and pharmacokinetics", 
    "pagination": "6-9", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "e4fb77f36f227a457a98f857951056f2d69c964902ba19220e941711a0bde12b"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9502557"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8708728"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s004670050391"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1048067036"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s004670050391", 
      "https://app.dimensions.ai/details/publication/pub.1048067036"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T22:25", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8690_00000483.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s004670050391"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s004670050391'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s004670050391'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s004670050391'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s004670050391'


 

This table displays all metadata directly associated to this object as RDF triples.

225 TRIPLES      21 PREDICATES      58 URIs      34 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s004670050391 schema:about N0dd09031ffbc46da8d28ba976b494d9c
2 N12c85e2267d94ed2852e8ab90542a167
3 N1edca82279e043c9980b34d3642a190d
4 N1f3de0e2af574a529df5b3018451deb5
5 N2d5432a4216e4679a4d99c24ae098b08
6 N5accd81a20eb4b978e3d8d845d9b4e9d
7 N7f01fa91a1fd450abf6e2c530f556fb7
8 N81c55a084cea41f3a9e3ce546181bd3e
9 Na52d0240157f4deba225dfd91c6ccab7
10 Naf09045efbaf406e986565cd87636443
11 Nb64bf8c2f9094b27a9410c6c46adee56
12 Ne32750c10a1e4db9813bd2f11d2fbf97
13 Nede55214089047098966c5addd72b151
14 anzsrc-for:11
15 anzsrc-for:1103
16 schema:author N2ee8f679fce54e0ba2e1a9e81edea2d5
17 schema:citation sg:pub.10.1007/bf00852868
18 sg:pub.10.1007/bf00861586
19 sg:pub.10.1007/bf00866315
20 sg:pub.10.1038/clpt.1986.177
21 https://doi.org/10.1001/jama.1989.03420240121038
22 https://doi.org/10.1002/hep.1840160202
23 https://doi.org/10.1002/jmv.1890400103
24 https://doi.org/10.1016/s0140-6736(95)92110-9
25 https://doi.org/10.1016/s0140-6736(96)90449-3
26 https://doi.org/10.1093/clinids/10.supplement_3.s507
27 https://doi.org/10.1093/infdis/152.4.833
28 https://doi.org/10.1093/infdis/155.3.565
29 https://doi.org/10.1093/ndt/8.9.858
30 https://doi.org/10.1097/00007890-199605150-00001
31 https://doi.org/10.1164/ajrccm.150.1.8025741
32 https://doi.org/10.7326/0003-4819-123-3-199508010-00008
33 schema:datePublished 1998-01
34 schema:datePublishedReg 1998-01-01
35 schema:description Ganciclovir alone or in combination with hyperimmunoglobulin is replacing other treatment modalities for the prophylactic treatment of cytomegalovirus (CMV) infections. No dose recommendations are available for oral ganciclovir therapy in children with impaired renal function after renal transplantation of a kidney from a CMV IgG-positive donor. We undertook a pharmacokinetic study in 14 pediatric renal transplant recipients who were CMV IgG negative and had received a graft from a CMV IgG-positive donor. We estimated the daily dosage of oral ganciclovir in relation to the glomerular filtration rate (GFR). Oral ganciclovir was administered at a starting dose of 3 x 1 g for children with a weight above 50 kg, 3 x 750 mg for children between 50 and 37.5 kg, and 3 x 500 mg for children between 37.5 and 24 kg. The starting dose was reduced by 50% for GFR values < or = 50 ml/min per 1.73 m2 and by 75% for GFR values < or = 25 ml/min per 1.73 m2. The daily dose was divided into three daily doses unless GFR was < 40 ml/ min per 1.73 m2, when only two daily doses were given. Doses were adjusted according to the measured plasma trough concentrations (c) using the simple formula: c(ganciclovir)(measured)/c(ganciclovir)(desired) = dosage rate(used)/dosage rate(adjusted). Mean stable plasma trough concentration was 0.91 +/- 0.68 microg/ml. The dosage rate, adjusted to a trough concentration of 1.0 microg/ml, correlated with the GFR. The dose per day could be calculated according to a simple equation for a GFR < 100 ml/min per 1.73 m2: dosage per day (mg/kg per day) = GFR. No CMV disease developed in any of the patients during oral ganciclovir, but 1 patient developed an acute rejection episode and a positive pp65 antigen 5 weeks after discontinuation of ganciclovir. The drug was well tolerated and without side effects.
36 schema:genre research_article
37 schema:inLanguage en
38 schema:isAccessibleForFree false
39 schema:isPartOf N138853271c4b4d0fa6e1610fcdeec957
40 N4b04fe84213240f19e9df81e49572fcb
41 sg:journal.1097267
42 schema:name Prophylactic oral ganciclovir after renal transplantation-dosing and pharmacokinetics
43 schema:pagination 6-9
44 schema:productId N7e8a094b531b4ed19cd4622a7c3c7bd6
45 Nb31d3cf8ed8445f2a02599a19515d048
46 Nbd8e46c160934bb2b46a0daa70a0dba9
47 Nc10949095c2b4ffa8638fe33c278a435
48 Nddcf1416c1784441bb15996a13ec0539
49 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048067036
50 https://doi.org/10.1007/s004670050391
51 schema:sdDatePublished 2019-04-10T22:25
52 schema:sdLicense https://scigraph.springernature.com/explorer/license/
53 schema:sdPublisher N0a9d9ad8b7cc44429e18a8d9ee0ac97b
54 schema:url http://link.springer.com/10.1007/s004670050391
55 sgo:license sg:explorer/license/
56 sgo:sdDataset articles
57 rdf:type schema:ScholarlyArticle
58 N033edbf8fd61447f9079d5f0618e44f6 schema:affiliation Nab660d09a7914b338bc1d90e060fdc3f
59 schema:familyName Rocher
60 schema:givenName Sonja
61 rdf:type schema:Person
62 N0a9d9ad8b7cc44429e18a8d9ee0ac97b schema:name Springer Nature - SN SciGraph project
63 rdf:type schema:Organization
64 N0dd09031ffbc46da8d28ba976b494d9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Kidney Transplantation
66 rdf:type schema:DefinedTerm
67 N12c85e2267d94ed2852e8ab90542a167 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Ganciclovir
69 rdf:type schema:DefinedTerm
70 N138853271c4b4d0fa6e1610fcdeec957 schema:volumeNumber 12
71 rdf:type schema:PublicationVolume
72 N182d2a53d52645e481393b3fdff626cc schema:name Institute of Clinical Toxicology and Pharmacology, BBGes, Berlin, Germany, DE
73 rdf:type schema:Organization
74 N1ea7cd1f04764e6683a0e174d012b492 rdf:first sg:person.012521232474.34
75 rdf:rest rdf:nil
76 N1edca82279e043c9980b34d3642a190d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Area Under Curve
78 rdf:type schema:DefinedTerm
79 N1f3de0e2af574a529df5b3018451deb5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Administration, Oral
81 rdf:type schema:DefinedTerm
82 N22e1d202a69a4d488dc0a3e821999d2c rdf:first sg:person.01327674261.68
83 rdf:rest N6e878fbcb3184d8c9d9f2f4ac2a52b1c
84 N2d5432a4216e4679a4d99c24ae098b08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Humans
86 rdf:type schema:DefinedTerm
87 N2ee8f679fce54e0ba2e1a9e81edea2d5 rdf:first sg:person.01071536417.49
88 rdf:rest N22e1d202a69a4d488dc0a3e821999d2c
89 N4410468c63c64878b608914c9137b5ae schema:name Department of Pediatric Nephrology, Charité Hospital, Humboldt University, Berlin, Germany, DE
90 rdf:type schema:Organization
91 N4a8735126f2e45c39d5fe13ef2b591da rdf:first sg:person.01005150043.93
92 rdf:rest Nd6661b39691542a89164b5eac3368641
93 N4b04fe84213240f19e9df81e49572fcb schema:issueNumber 1
94 rdf:type schema:PublicationIssue
95 N5accd81a20eb4b978e3d8d845d9b4e9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Cytomegalovirus Infections
97 rdf:type schema:DefinedTerm
98 N6e878fbcb3184d8c9d9f2f4ac2a52b1c rdf:first sg:person.01030242017.91
99 rdf:rest N4a8735126f2e45c39d5fe13ef2b591da
100 N7e8a094b531b4ed19cd4622a7c3c7bd6 schema:name dimensions_id
101 schema:value pub.1048067036
102 rdf:type schema:PropertyValue
103 N7f01fa91a1fd450abf6e2c530f556fb7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Child
105 rdf:type schema:DefinedTerm
106 N81c55a084cea41f3a9e3ce546181bd3e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Antiviral Agents
108 rdf:type schema:DefinedTerm
109 N9fe48c495a0741ef84409a77a3467b94 schema:name Institute of Clinical Toxicology and Pharmacology, BBGes, Berlin, Germany, DE
110 rdf:type schema:Organization
111 Na52d0240157f4deba225dfd91c6ccab7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Injections, Intravenous
113 rdf:type schema:DefinedTerm
114 Nab660d09a7914b338bc1d90e060fdc3f schema:name Institute of Clinical Toxicology and Pharmacology, BBGes, Berlin, Germany, DE
115 rdf:type schema:Organization
116 Naf09045efbaf406e986565cd87636443 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Male
118 rdf:type schema:DefinedTerm
119 Nb056e6bae90b4f55b8535a09cf599e45 rdf:first sg:person.0726536625.99
120 rdf:rest N1ea7cd1f04764e6683a0e174d012b492
121 Nb31d3cf8ed8445f2a02599a19515d048 schema:name pubmed_id
122 schema:value 9502557
123 rdf:type schema:PropertyValue
124 Nb40a695ca5a340c7bdfbdf655cbc1879 schema:name Department of Pediatric Nephrology, Charité Hospital, Humboldt University, Berlin, Germany, DE
125 rdf:type schema:Organization
126 Nb64bf8c2f9094b27a9410c6c46adee56 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Female
128 rdf:type schema:DefinedTerm
129 Nbd8e46c160934bb2b46a0daa70a0dba9 schema:name nlm_unique_id
130 schema:value 8708728
131 rdf:type schema:PropertyValue
132 Nc10949095c2b4ffa8638fe33c278a435 schema:name readcube_id
133 schema:value e4fb77f36f227a457a98f857951056f2d69c964902ba19220e941711a0bde12b
134 rdf:type schema:PropertyValue
135 Nc2dec9595a9845098212db2f02ed350b schema:name Department of Pediatric Nephrology, Charité Hospital, Humboldt University, Berlin, Germany, DE
136 rdf:type schema:Organization
137 Nd6661b39691542a89164b5eac3368641 rdf:first N033edbf8fd61447f9079d5f0618e44f6
138 rdf:rest Nb056e6bae90b4f55b8535a09cf599e45
139 Nd8aef388d5854b8fa1d1fc33540ad2ac schema:name Department of Pediatric Nephrology, Charité Hospital, Humboldt University, Berlin, Germany, DE
140 rdf:type schema:Organization
141 Nddcf1416c1784441bb15996a13ec0539 schema:name doi
142 schema:value 10.1007/s004670050391
143 rdf:type schema:PropertyValue
144 Ne32750c10a1e4db9813bd2f11d2fbf97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Biological Availability
146 rdf:type schema:DefinedTerm
147 Nede55214089047098966c5addd72b151 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Adolescent
149 rdf:type schema:DefinedTerm
150 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
151 schema:name Medical and Health Sciences
152 rdf:type schema:DefinedTerm
153 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
154 schema:name Clinical Sciences
155 rdf:type schema:DefinedTerm
156 sg:journal.1097267 schema:issn 0931-041X
157 1432-198X
158 schema:name Pediatric Nephrology
159 rdf:type schema:Periodical
160 sg:person.01005150043.93 schema:affiliation N182d2a53d52645e481393b3fdff626cc
161 schema:familyName Lappenberg-Pelzer
162 schema:givenName Marianne
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005150043.93
164 rdf:type schema:Person
165 sg:person.01030242017.91 schema:affiliation Nd8aef388d5854b8fa1d1fc33540ad2ac
166 schema:familyName von Bredow
167 schema:givenName Moritz A.
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030242017.91
169 rdf:type schema:Person
170 sg:person.01071536417.49 schema:affiliation N4410468c63c64878b608914c9137b5ae
171 schema:familyName Filler
172 schema:givenName Guido
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071536417.49
174 rdf:type schema:Person
175 sg:person.012521232474.34 schema:affiliation Nc2dec9595a9845098212db2f02ed350b
176 schema:familyName Ehrich
177 schema:givenName Jochen H. H.
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012521232474.34
179 rdf:type schema:Person
180 sg:person.01327674261.68 schema:affiliation N9fe48c495a0741ef84409a77a3467b94
181 schema:familyName Lampe
182 schema:givenName Dagmar
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327674261.68
184 rdf:type schema:Person
185 sg:person.0726536625.99 schema:affiliation Nb40a695ca5a340c7bdfbdf655cbc1879
186 schema:familyName Strehlau
187 schema:givenName Jürgen
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726536625.99
189 rdf:type schema:Person
190 sg:pub.10.1007/bf00852868 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032557089
191 https://doi.org/10.1007/bf00852868
192 rdf:type schema:CreativeWork
193 sg:pub.10.1007/bf00861586 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009391840
194 https://doi.org/10.1007/bf00861586
195 rdf:type schema:CreativeWork
196 sg:pub.10.1007/bf00866315 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017583818
197 https://doi.org/10.1007/bf00866315
198 rdf:type schema:CreativeWork
199 sg:pub.10.1038/clpt.1986.177 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048491269
200 https://doi.org/10.1038/clpt.1986.177
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1001/jama.1989.03420240121038 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036498475
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1002/hep.1840160202 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014545792
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1002/jmv.1890400103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035171393
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1016/s0140-6736(95)92110-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020852311
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1016/s0140-6736(96)90449-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025511504
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1093/clinids/10.supplement_3.s507 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059470685
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1093/infdis/152.4.833 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059699619
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1093/infdis/155.3.565 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059700292
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1093/ndt/8.9.858 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082724330
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1097/00007890-199605150-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060275860
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1164/ajrccm.150.1.8025741 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011029637
223 rdf:type schema:CreativeWork
224 https://doi.org/10.7326/0003-4819-123-3-199508010-00008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073699813
225 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...